Discover endless research opportunities. Choose your disease area.

New Call-to-action New Call-to-action New Call-to-action New Call-to-action New Call-to-action

Request Tissue Sample Pricing & Availability

At Conversant Bio we offer a wide variety of fresh and frozen human primary cells that can target virtually any disease, stage or grade with detailed patient annotation. From peripheral blood, bone marrow, processed and whole tissue, xenograft tumor cells, and other human biospecimens, we can meet your research needs.


Researchers Guide to Immunology

FREE EBOOK: A Researcher's Guide to Immunology

Most autoimmune disease research revolves around understanding the nuances of diseases in order to develop potential treatment options. High quality biospecimens are an important part of this work.

Autoimmune disease biospecimens open up possibilities to advance your immunology research through sample specificity and flexibility. Downlaod this free ebook and learn new research discoveries and challenges, auto-immune treatments and medications, and much more!



FREE EBOOK: A Researcher's Guide to Multiple Myeloma

Multiple myeloma is a hematologic cancer that develops in the bone marrow of the long bones. In the search to find a cure for multiple myeloma, understanding how multiple myeloma is diagnosed and treated in the real world is key. In this free guide learn how multiple myeloma is diagnosed through lab work and imaging, the typical stages and criterion for multiple myeloma, treatment options for the disease and the most common research challenges and how to solve them. Download today!


See What People Are Saying

"The rate limiting step in our research into human disease is access to high-quality, well-characterized tissues. Conversant Bio is an incredible resource that has come along at the right time; their specimens are opening doors to research we never imagined possible in years past."

Rick Myers, PhD, President and Director, HudsonAlpha Institute

"We need good quality samples so that we can understand the expression of our drug targets, to identify whether or not the drug is working in the manner we expect it to."

Scott Patterson, PhD, Executive Director, Amgen, Inc.

Read Our Recent Blog Posts

Companies That Trust Us!

Companies That Trust Us